Reaction
Injection Site Cyst reporting signals
As of the last recalculation, Injection Site Cyst appears in 290 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is NALTREXONE (PRR 92.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Naltrexone | 35 | 92.5 | 92.6 |
| Lanreotide Acetate | 4 | 37.1 | 37.1 |
| Paliperidone Palmitate | 13 | 30.3 | 30.3 |
| Cabotegravir | 3 | 26.9 | 26.9 |